News Daily News FOURIER Analysis: Evolocumab Delivers Consistent LDL Cholesterol-Lowering Yael L. Maxwell December 19, 2018
News Conference News AHA 2018 EWTOPIA 75: Ezetimibe Bests Dietary Counseling Alone in Lowering Cardiovascular Risk for Elderly Japanese Patients Yael L. Maxwell November 16, 2018
News Daily News ODYSSEY Outcomes Published as New Cholesterol Guidelines Loom Michael O'Riordan November 07, 2018
News Daily News Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60% Michael O'Riordan October 25, 2018
News Daily News Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show Michael O'Riordan October 17, 2018
News Daily News Starting Low and Going Lower: Some Benefit to Very Low LDL Levels Michael O'Riordan August 02, 2018
News Daily News Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women Yael L. Maxwell July 09, 2018
News Conference News EAS 2018 EAS Consensus Document Examines Safety of Statins Beyond Muscle Symptoms Yael L. Maxwell May 11, 2018
News Conference News EAS 2018 Unlocking Lp(a): Baseline Levels Matter, but So Too Does Absolute Reduction Yael L. Maxwell May 08, 2018
Presentation EAS 2018 Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial Presenter: Michelle L. O’Donoghue May 07, 2018
News Daily News LPA Variants Linked With CHD Events in Statin-Treated Patients Michael O'Riordan May 03, 2018
News Daily News The Higher the LDL, the Bigger the Mortality Benefit of Intensive Therapy: Meta-analysis Michael O'Riordan April 20, 2018
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2018 Shelley Wood April 02, 2018
News Industry News Amgen Receives Positive CHMP Opinion Recognizing That Repatha® (evolocumab) Prevents Heart Attacks And Strokes March 23, 2018
News Conference News ACC 2018 High CRP Linked to Bigger Absolute Drops in CV Events for Patients Taking Evolocumab Michael O'Riordan March 20, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Conference News ACC 2018 ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018